153 related articles for article (PubMed ID: 2554104)
1. Plasma ouabain-like activity in essential hypertensive patients and in subjects with primary aldosteronism.
Delva P; Degan M; Capra C; Fallo F; Mantero F; Menegazzi M; Lechi C; Steele A; Lechi A
Miner Electrolyte Metab; 1989; 15(5):315-20. PubMed ID: 2554104
[TBL] [Abstract][Full Text] [Related]
2. [Endogenous ouabain--key to the genesis of hypertension?].
Blaustein MP; Hamlyn JM
Dtsch Med Wochenschr; 1991 Nov; 116(44):1689-91. PubMed ID: 1657565
[No Abstract] [Full Text] [Related]
3. Ouabain, digitalis-like factors and hypertension.
Hamlyn JM; Manunta P
J Hypertens Suppl; 1992 Dec; 10(7):S99-111. PubMed ID: 1337913
[TBL] [Abstract][Full Text] [Related]
4. The role of endogenous digitalis-like factor in blood pressure regulation in essential hypertension.
Suchmanová-Lazúrová I; Lichardus B; Rosochová I; Pjescák M; Trejbal D; Murár J; Machánová Y
Wien Klin Wochenschr; 1994; 106(16):513-6. PubMed ID: 7975661
[TBL] [Abstract][Full Text] [Related]
5. Recent progress on an endogenous digitalislike factor in hypertension.
Cloix JF; Crabos M; Meyer P
J Clin Hypertens; 1986 Jun; 2(2):93-100. PubMed ID: 3020179
[TBL] [Abstract][Full Text] [Related]
6. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
7. Normalization of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma.
Masugi F; Ogihara T; Hasegawa T; Sakaguchi K; Kumahara Y
J Hum Hypertens; 1988 Jun; 2(1):17-20. PubMed ID: 3236314
[TBL] [Abstract][Full Text] [Related]
8. Acute hypotensive effect of calcium antagonists and endogenous digitalis-like immunoreactivity in human essential hypertension.
Palombo C; Marabotti C; Genovesi-Ebert A; Del Chicca MG; Balzan S; Giaconi S; Fommei E; Gazzetti P; Clerico A; Ghione S
J Hypertens Suppl; 1986 Dec; 4(5):S461-4. PubMed ID: 3033184
[TBL] [Abstract][Full Text] [Related]
9. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
10. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
[TBL] [Abstract][Full Text] [Related]
11. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
[TBL] [Abstract][Full Text] [Related]
12. Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly.
Deray G; Rieu M; Devynck MA; Pernollet MG; Chanson P; Luton JP; Meyer P
N Engl J Med; 1987 Mar; 316(10):575-80. PubMed ID: 3027557
[TBL] [Abstract][Full Text] [Related]
13. Plasma endogenous sodium pump inhibitor in essential hypertension.
Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
[TBL] [Abstract][Full Text] [Related]
14. Circulating factor with ouabain-like immunoreactivity in patients with primary aldosteronism.
Masugi F; Ogihara T; Hasegawa T; Tomii A; Nagano M; Higashimori K; Kumahara K; Terano Y
Biochem Biophys Res Commun; 1986 Feb; 135(1):41-5. PubMed ID: 3006685
[TBL] [Abstract][Full Text] [Related]
15. The role of endogenous Na+, K(+)-adenosine triphosphatase inhibitory factor in the regulation of membrane fluidity of erythrocytes in essential hypertension.
Tsuda K; Shima H; Takeda J; Kimura K; Nishio I; Masuyama Y
J Hypertens; 1992 Jul; 10(7):657-61. PubMed ID: 1321193
[TBL] [Abstract][Full Text] [Related]
16. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
[TBL] [Abstract][Full Text] [Related]
17. Increased concentrations of a circulating sodium pump inhibitor in essential hypertension and uraemia and its partial purification from haemofiltrate.
Wenzel M; Heidrich E; Kirch U; Moreth-Wolfrat K; Wizemann V; Schoner W
Physiol Bohemoslov; 1990; 39(1):79-85. PubMed ID: 2165269
[TBL] [Abstract][Full Text] [Related]
18. Plasma digitalis-like activity and cytosolic Ca2+ in essential hypertension.
Le Quan Sang KH; Pernollet MG; Meyer P; Devynck MA
Am J Hypertens; 1990 Mar; 3(3):171-5. PubMed ID: 2157464
[TBL] [Abstract][Full Text] [Related]
19. [Compounds of the digoxin type in essential and experimental hypertension].
Pernollet MG; Wauquier I; Grichois ML; de Mendonça M; Meyer P; Devynck MA
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):882-7. PubMed ID: 2432846
[TBL] [Abstract][Full Text] [Related]
20. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
